Vitalcare Hospice 3956 Bluebonnet Drive, Stafford, TX, 77477 | |
(281) 494-5141 |
News Archive
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
To help scientists and science trainees who hope to translate laboratory research into clinical medicine and to help minority scientists navigate their career paths, AAAS, Science Careers, and Science are launching a pair of online social-networking sites.
The Boston Globe's Business Updates: Massachusetts' "four biggest health insurers today posted first-quarter losses totalling more than $150 million, with three of the carriers blaming the bulk of their deficit on the Patrick administration's decision to cap rate increases for individuals and small businesses." Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan and Fallon Community Health Plan all reported loses.
› Verified 8 days ago
Name | Vitalcare Hospice |
---|---|
Location | 3956 Bluebonnet Drive, Stafford, Texas |
Hospice ID | 741527 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 720 |
News Archive
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
To help scientists and science trainees who hope to translate laboratory research into clinical medicine and to help minority scientists navigate their career paths, AAAS, Science Careers, and Science are launching a pair of online social-networking sites.
The Boston Globe's Business Updates: Massachusetts' "four biggest health insurers today posted first-quarter losses totalling more than $150 million, with three of the carriers blaming the bulk of their deficit on the Patrick administration's decision to cap rate increases for individuals and small businesses." Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan and Fallon Community Health Plan all reported loses.
› Verified 8 days ago
NPI Number | 1366985376 |
Organization Name | Autumncare Health Services Llc |
Address | 3956 Bluebonnet Dr Stafford, Texas, 77477 |
Phone Number | (713)557-3296 |
News Archive
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
To help scientists and science trainees who hope to translate laboratory research into clinical medicine and to help minority scientists navigate their career paths, AAAS, Science Careers, and Science are launching a pair of online social-networking sites.
The Boston Globe's Business Updates: Massachusetts' "four biggest health insurers today posted first-quarter losses totalling more than $150 million, with three of the carriers blaming the bulk of their deficit on the Patrick administration's decision to cap rate increases for individuals and small businesses." Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan and Fallon Community Health Plan all reported loses.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
To help scientists and science trainees who hope to translate laboratory research into clinical medicine and to help minority scientists navigate their career paths, AAAS, Science Careers, and Science are launching a pair of online social-networking sites.
The Boston Globe's Business Updates: Massachusetts' "four biggest health insurers today posted first-quarter losses totalling more than $150 million, with three of the carriers blaming the bulk of their deficit on the Patrick administration's decision to cap rate increases for individuals and small businesses." Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan and Fallon Community Health Plan all reported loses.
› Verified 8 days ago
Home Health Aides | 1 |
Counselors | 1 |
Medical Social Workers | 1 |
Registered Nurses | 2 |
Other Personnel | 1 |
Total Employees | 6 |
---|
News Archive
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
To help scientists and science trainees who hope to translate laboratory research into clinical medicine and to help minority scientists navigate their career paths, AAAS, Science Careers, and Science are launching a pair of online social-networking sites.
The Boston Globe's Business Updates: Massachusetts' "four biggest health insurers today posted first-quarter losses totalling more than $150 million, with three of the carriers blaming the bulk of their deficit on the Patrick administration's decision to cap rate increases for individuals and small businesses." Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan and Fallon Community Health Plan all reported loses.
› Verified 8 days ago
Others | 1 |
Total Volunteers | 1 |
---|
News Archive
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
A vitamin D boost may prevent early death from heart disease and cancer, according to a large scale study by Mount Sinai and a consortium of international collaborators, published online in the June issue of BMJ.
The University of Michigan Health System doesn't claim to be perfect. But its response to medical errors, near-misses, unexpected clinical problems and unintended outcomes is a model for the nation that other hospitals can and should copy, according to a new paper in a prestigious health care journal.
To help scientists and science trainees who hope to translate laboratory research into clinical medicine and to help minority scientists navigate their career paths, AAAS, Science Careers, and Science are launching a pair of online social-networking sites.
The Boston Globe's Business Updates: Massachusetts' "four biggest health insurers today posted first-quarter losses totalling more than $150 million, with three of the carriers blaming the bulk of their deficit on the Patrick administration's decision to cap rate increases for individuals and small businesses." Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan and Fallon Community Health Plan all reported loses.
› Verified 8 days ago
Silverado Hospice - South Houston Location: 4800 Sugar Grove Blvd Suite 390, Stafford, Texas, 77477 Phone: (281) 494-5141 |
Elysian Hospice Location: 11104 West Airport Boulevard Suite 255b, Stafford, Texas, 77477 Phone: (281) 494-5141 |
Heavenly Hospice @ Home, Llc Location: 445 Fm 1092 Suite 101g, Stafford, Texas, 77477 Phone: (281) 494-5141 |
Benevolent Hospice Of Houston Llc Location: 10701 Corporate Drive Suite 356, Stafford, Texas, 77477 Phone: (281) 494-5141 |